Homocysteine and heart failure: a review of investigations from the Framingham Heart Study
- 1 January 2005
- journal article
- review article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 43 (10) , 987-992
Abstract
High plasma homocysteine levels are associated with a moderately increased risk of cardiovascular disease, particularly of atherosclerotic events. We review the association of plasma homocysteine with heart failure, with a specific focus on a series of previously published investigations from the community-based Framingham Heart Study that evaluated the relations of plasma homocysteine levels with overt heart failure, and with its key antecedents, echocardiographic left ventricular (LV) mass and hypertension. In the Framingham sample, higher plasma homocysteine levels were associated with increased risk of new-onset heart failure in both men and women, with a more continuous and graded relation being observed in women. A positive relation between homocysteine and LV mass was observed in women, but not in men; this may underlie the stronger relations of homocysteine to heart failure risk in women. Plasma homocysteine was not associated with hypertension incidence prospectively in either sex. The relations of increased homocysteine to heart failure (in both sexes) and to greater LV mass (in women) noted in the Framingham sample should be confirmed in other community-based samples. Secondary analyses of heart failure outcomes in ongoing randomized clinical trials may provide insights into whether lowering of plasma homocysteine levels is associated with a reduction in LV mass and/or a reduction of heart failure risk.Keywords
This publication has 46 references indexed in Scilit:
- Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patientsCoronary Artery Disease, 2005
- Extracellular Matrix Remodeling in the Heart of the Homocysteinemic Obese RabbitAmerican Journal of Hypertension, 2005
- Acute negative inotropic effects of homocysteine are mediated via the endotheliumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart StudyEuropean Heart Journal, 2004
- Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitaminsAmerican Journal of Hypertension, 2002
- Hyperhomocysteinemia Evoked by Folate DepletionArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Estrogen and homocysteineCardiovascular Research, 2002
- Induction of oxidative stress by homocyst(e)ine impairs endothelial function*Journal of Cellular Biochemistry, 2001
- Acute hyperhomocysteinaemia and endothelial dysfunctionThe Lancet, 1998
- Sex differences in cardiac adaptation to isolated systolic hypertensionThe American Journal of Cardiology, 1993